Lifestyle
- Regular physical activity
- Stress management techniques
- Adequate sleep
Tumor Necrosis Factor Alpha · TNF-alpha · TNFa
TNF-α quantifies the concentration of tumor necrosis factor-alpha, a cytokine involved in inflammation and immune system regulation.
Reference ranges may vary based on assay and laboratory standards.
Tumor Necrosis Factor-alpha (TNF-α) is a pro-inflammatory cytokine involved in systemic inflammation and is part of the body's immune response. It is produced by various cell types, including macrophages, lymphocytes, and certain tumor cells. TNF-α plays a crucial role in the regulation of immune cells, the induction of fever, apoptotic cell death, and inflammation. Clinically, TNF-α is significant in the pathogenesis of several autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn's disease, psoriasis, and certain cancers. Elevated levels of TNF-α are often associated with chronic inflammatory conditions and can be indicative of disease activity or severity. In the context of athletic performance and biohacking, TNF-α is relevant as it can influence recovery times and inflammation levels, potentially impacting performance and overall health. However, the interpretation of TNF-α levels can be confounded by factors such as acute infections, stress, and circadian rhythms. It is important to consider these variables when assessing TNF-α levels, and testing should ideally be conducted under standardized conditions to ensure accuracy.
Klinische Bedeutung
Elevated TNF-α levels indicate active inflammation and are associated with autoimmune diseases, infections, and certain cancers. Reduced levels may suggest effective anti-inflammatory treatment or remission of disease.
Progressively rising TNF-α levels suggest worsening inflammation or disease activity. Re-test in 4 weeks if levels are significantly elevated.
Progressively falling TNF-α levels may indicate effective treatment or disease remission.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any new supplement regimen, especially if you have underlying health conditions.
TNF-α levels can vary throughout the day; morning samples may provide more consistent results.
Testing Frequency
Annually for individuals with chronic inflammatory conditions or as directed by a healthcare provider.
Correlated with
Current research suggests that the reference ranges for TNF-α levels in various diseases, such as diabetic retinopathy, remain debated, particularly regarding confounding factors like sample size and patient demographics. Researchers have not yet established optimal targets for TNF-α in predicting treatment responses across autoimmune disorders. Additionally, clinical questions remain unanswered regarding the precise role of TNF-α in the pathogenesis of gastric cancer and its potential as a reliable biomarker for other inflammatory diseases.
777
Total Citations
3
Human/RCT
2.4
Avg. Influence
2025
Latest
Researchers reviewed the potential of salivary cytokines, including TNF-α, as diagnostic biomarkers for oral cancer. They noted that elevated levels of these cytokines are associated with cancer progression. The study suggests that saliva could be a cost-effective medium for early detection of oral squamous cell carcinoma.
This study reviewed the development and applications of anti-TNF-alpha therapies, which have significantly improved treatment for autoimmune diseases like rheumatoid arthritis and Crohn's disease. Researchers found that five anti-TNF-alpha drugs are currently approved, and there is ongoing research into their potential use in other conditions, including COVID-19 and certain cancers.
This review highlighted the role of myeloperoxidase (MPO) and TNF-alpha in neuroinflammation. Researchers suggested that targeting MPO may provide a new diagnostic and therapeutic avenue for neurological disorders.
This review focused on the role of TNF-alpha in COVID-19, noting its contribution to lung inflammation and tissue damage. Researchers proposed TNF-alpha as a potential biomarker for severe COVID-19 prognosis and a target for therapy.
This review discussed the role of chemerin and TNF-alpha in obesity-related inflammatory diseases. Researchers observed that chemerin levels increase in various inflammatory conditions, and it may serve as a biomarker for both benign and malignant tumors.
Researchers conducted a meta-analysis to assess the link between serum TNF-α levels and recurrent spontaneous miscarriage (RSM). They found that TNF-α levels were significantly higher in RSM patients compared to controls, suggesting a potential role of TNF-α in miscarriage risk. The study highlights the need for standardized testing methods.
Researchers explored the dual roles of TNF-α in lung cancer, noting its potential to promote both tumor survival and immune response. They highlighted the importance of the balance between TNF-α forms and receptors in cancer progression. The study calls for further research into TNF-α as a biomarker for lung cancer treatment.
Researchers reviewed the impact of hypothyroidism on cardiovascular disease, noting elevated TNF-alpha levels in atherosclerotic plaques. They discussed how thyroid hormone replacement therapy may help mitigate cardiovascular risks associated with hypothyroidism.
This meta-analysis investigated the relationship between TNF-alpha levels and diabetic retinopathy. Researchers found no significant difference in TNF-alpha levels between diabetic retinopathy patients and healthy controls, suggesting TNF-alpha may not be a reliable biomarker for this condition.
Researchers found that TNF-α inhibits the differentiation of cementoblasts, which are essential for dental health. They identified microRNA-155-3p as a mediator of this inhibition, affecting cementoblast mineralization through the Wnt signaling pathway. This study highlights the complex interactions between inflammatory cytokines and dental cell function.
Research publications about TNF-alpha over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer